跳至主要内容
临床试验/NCT01905930
NCT01905930已完成3 期

A Prospective, Randomized, Multi-Center, Post-Approval Clinical Trial Evaluating the Long-Term (7 Year) Safety and Effectiveness of the PCM® Cervical Disc

NuVasive36 个研究点 分布在 1 个国家目标入组 494 人开始时间: 2013年4月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
494
试验地点
36
主要终点
Individual Patient Overall Success

研究概览

简要总结

On October 26, 2012, the FDA granted Premarket Approval (PMA) for the PCM Cervical Disc. PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit), with or without neck pain, or myelopathy due to a single-level abnormality localized to the disc space, and manifested by at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels.

The purpose of this post-approval study is to evaluate the long-term (7 year) safety and effectiveness of the PCM Cervical Disc.

详细描述

A prospective, multi-center, post approval study with concurrent control group consisting of those patients that were enrolled and did not fail in the PCM Cervical Disc IDE clinical study and will to give consent to participate.

All of the PCM IDE investigational sites who have active patients will be chosen to participate in this study. All patients who are actively participating in the pivotal IDE study will be asked to participate in this study.

The study consists of follow-up periods only. The follow-up period will last for seven years from each patient's surgery date.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients enrolled in the PCM Cervical Disc IDE clinical study
  • Patients willing and able to give informed consent

排除标准

  • Patients considered failure during the PCM Cervical Disc IDE clinical study
  • Patients who were withdrawn during the PCM Cervical Disc IDE clinical study

结局指标

主要结局

Individual Patient Overall Success

时间窗: 7 years

* Improvement of at least 20% on the Neck Disability Index (NDI) at 7 years compared to baseline * No device failures requiring revision, reoperation, removal or supplemental fixation * No major complications such as vascular or neurological injury * Radiographic success

次要结局

未报告次要终点

研究者

发起方
NuVasive
申办方类型
Industry
责任方
Sponsor

研究点 (36)

Loading locations...

相似试验